HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates

Thromb Haemost. 1988 Jun 16;59(3):396-9.

Abstract

A national multicentre study was performed to investigate the effects of donorselection and the use of heat-treated plasma products on seroconversion to HIV in 157 Dutch haemophiliacs. All patients included in the study were seronegative for HIV antibodies in 1983. Thirteen percent (20/157) seroconverted between 1983 and 1986. Nineteen of 20 seroconversions could be related to the use of non heat-treated products in the year preceding HIV antibody seroconversion. One seroconversion occurred in a person using heat-treated non donor screened product. Seroconversion rate decreased as a result of the policy to discourage high risk blood donors and no seroconversions were observed following the introduction of donor screening in 1985.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Coagulation Factors / adverse effects*
  • Factor VIII / therapeutic use
  • Follow-Up Studies
  • HIV Seropositivity / epidemiology
  • HIV Seropositivity / etiology*
  • Hemophilia A / therapy*
  • Hot Temperature
  • Humans
  • Multicenter Studies as Topic
  • Netherlands

Substances

  • Blood Coagulation Factors
  • Factor VIII